1. The controls were 713 postmenopausal women aged 45-65 not taking hormone replacements.

2. So different are the careers of pre-menopausal and post-menopausal cancer that they should be treated as different diseases.

3. Forty seven postmenopausal women aged 44 to 67 years were studied.

4. Only the benefits of estrogen replacement therapy have been clinically proven: It guards against heart disease and osteoporosis in post-menopausal women.

5. Antinori has a reputation as a renegade because of his many successful efforts to help post-menopausal women become pregnant.

6. She begins to feel like an unwanted post-menopausal monster in his home.

7. This inverse association was primarily confined to postmenopausal women.

8. This is because postmenopausal women rarely retain the flaxen locks of their youth, of course eventually becoming grey grannies.

9. To observe the application effect of naproxen on postmenopausal women with intrauterine device.

10. Conclusions The characteristics of ASCUS in postmenopausal women is that the rate of cervix diseases is low, and the prognosis of ASCUS is good.

11. Helps to alleviate premenstrual syndrome, menopausal symptoms and postmenopausal syndromes.

12. The volunteers, all postmenopausal women who are not taking HRT, will be into two groups.

13. Tamoxifen improves bone density in postmenopausal women, and there is some evidence of fracture reduction.

13. try its best to collect and make good sentences.

14. Postmenopausal osteoporosis ( PMOF ) is the common disease, frequently - occurring disease after menopause.

15. The FDA notes that adding a progestin to postmenopausal estrogen therapy has been shown to reduce the risk for endometrial hyperplasia, which may be a precursor to endometrial cancer.

16. Postmenopausal women sometimes have breast pain, but the symptom is more common in younger, premenopausal women and perimenopausal women.

17. Results:The main cause of postmenopausal uterine bleeding were malignant or benign uterine diseases, ovariotubal tumor secreting sex hormone and hormone replacement therapy.

18. Postmenopausal women with uterus in situ receiv - ing unopposed estrogen replacement therapy.

19. Conclusion Decreased PKC positive cells in the preoptic area may be associated with endocrine disturbance in postmenopausal women.

20. This hypothesis was recently confirmed by a study that found a reduced risk of invasive breast cancer among postmenopausal women with high lignan levels in their diet, Clavel-Chapelon said.

21. Objective : To retrospectively analyze the clinical characteristics and outcomes of endometrial carcinoma ( EC ) in postmenopausal patients.

22. Objective: Investigating the relation between the age, duration of menopause and pathologic type Postmenopausal uterus bleeding.

23. Objective: To compare the impact of two different kinds of kinesiotherapy - jogging and dancing on bone metabolism and bone mineral density(BMD) in postmenopausal women.

24. Conclusions The polymorphism of CTR gene was associated with BMD in postmenopausal women.

25. AIM : To observe the clinical effects of alfacalcidol the treatment of postmenopausal osteoporosis.

26. Clinical effect of intravaginal estriol suppository on senile vaginitis in 90 postmenopausal women.

27. Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.

28. Objective: To contrast the therapeutic effect of moxibustion and estrin replacement therapy on postmenopausal osteoporosis(PMO).

29. It is a common breast disease natural course of disease in various countries it will self-limited more than postmenopausal ease.

30. Objective To analyze the CT appearance of centrum compression in postmenopausal patients with primary spinal osteoporosis.

31. Methods:32 cases of postmenopausal colpoxerosis were treated by FJG, and the clinical symptoms scoring and level of sexual hormones were observed.

32. Urinary tract infection. Recurrent urinary tract infections are a problem for many postmenopausal women.

33. Estrogen-replacement therapy is the most effective available agent for those postmenopausal women because it inhibits bone reabsorption .

34. Objective: To investigate the causes of postmenopausal vagina bleeding and the value of dilation and curettage.

35. Objective To observe the effect of progressive resistance exercise combined with alendronate sodium on bone mineral density(BMD)of lumbar spine in patients with postmenopausal osteoporosis.

36. A pattern of rapidly rising rates with age was seen for cervical and trochanteric hip fractures among postmenopausal women. 87.6 percent of all female cases occurred within 30 years after menopause.

37. D . Postmenopausal women should perform breast self - examination on the same day of each month.

38. To explore the therapeutic effect and mechanism of Jiangu granule ( JGG ) on postmenopausal osteoporosis.

39. The combination drug was as an alternative treatment to classic estrogen replacement therapy in postmenopausal women.

40. Among both pre- and postmenopausal women, the most prevalent sexual problem is chronic low sexual desire, or hypoactive sexual desire disorder (HSDD).

41. Objective:To evaluate the short-term therapeutic efficacy of parathyroid hormone and calcitonin in postmenopausal osteoporotic women.

42. Many factors can impact bone metabolism, the relationship between estrin and postmenopausal is more important.

43. The effects of nylestriol and misoprostol are equal on the extraction of contraceptive device in postmenopausal women. Both drugs are curative and safe.

44. Alendronate is used to reduce bone loss, increase bone density and reduce the risk of spine, wrist and hip fractures in postmenopausal women.

45. The report found strong evidence that secondhand smoke contributed to premenopausal breast cancer, but did not find enough support to say it increased the risk of postmenopausal breast cancer.

46. Women who are menopausal or postmenopausal produce less estrogen and that leads to bone loss.

47. AIM:To study the effects of progesterone on normal adult osteoblasts so as to prove the hypothetical mechanism of progestogen in treating postmenopausal osteoporosis.

48. Men and postmenopausal women need only around 8 mg a day, while premenopausal women need 18 mg a day.

49. AIM : To observe the application effect of naproxen on postmenopausal women with intraute rine device.

50. Women who have completed childbearing or are postmenopausal would be the most appropriate candidates for UFE.

51. Conclusion Endometrial atrophy with bleeding and endometritis are the chief causes of postmenopausal uterine bleeding, and metroscopy is a reliable diagnostic tool.

52. Here is a normal uterus with fallopian tubes and ovaries from an older postmenopausal woman.

53. Methods The ovariectomized (OVX) rats were used as a model of postmenopausal osteoporosis to induce mandibular bone loss.

54. Results The average age of postmenopausal group was ( 60.40±10.07 ) ; and ( 48.40±5.40 ) in premenopausal group.

55. Methods: 36 cases of postmenopausal osteoporosis were collected and divided into two groups, which were randomly divided into two groups:raloxifene group and alendronate group.

56. Most studies hae not examined these associations in a large group of postmenopausal women.

57. CONCLUSION:Application of nelestriol plus misoprostol to intrauterine device removal could alleviate the postmenopausal woman's suffering and raise the success rate of procedure.

58. Objective: To compare the response and adverse reactions of aminoglutethimide with that of femara, an oral aromatase inhibitor, in postmenopausal women with advanced breast cancer.

59. Conclusion The decrease of endogenous level in postmenopausal women might serve anetiological factor for AD.